DOCSLIB.ORG

Structural Characterization of an Activin Class Ternary Receptor Complex Reveals a Third Paradigm for Receptor Specificity

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structural Characterization of an Activin Class Ternary Receptor Complex Reveals a Third Paradigm for Receptor Specificity Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity Erich J. Goebela, Richard A. Corpinab, Cynthia S. Hinckc, Magdalena Czepnika, Roselyne Castonguayd, Rosa Grenhad, Angela Boisvertd, Gabriella Miklossye, Paul T. Fullertone, Martin M. Matzuke, Vincent J. Idoneb, Aris N. Economidesb, Ravindra Kumard, Andrew P. Hinckc, and Thomas B. Thompsona,1 aDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267; bSkeletal Diseases Therapeutic Focus Area, Regeneron Pharmaceuticals, Tarrytown, NY 10591; cDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260; dDiscovery Group, Acceleron Pharma, Cambridge, MA 02139; and eDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030 Edited by K. Christopher Garcia, Stanford University, Stanford, CA, and approved June 24, 2019 (received for review April 18, 2019) TGFβ family ligands, which include the TGFβs, BMPs, and activins, I receptors with higher affinity than TGFβ class ligands (5, 6). signal by forming a ternary complex with type I and type II recep- Structural studies describing ligand–receptor interactions have tors. For TGFβs and BMPs, structures of ternary complexes have revealed how TGFβ and BMP ligands adopt different strategies to revealed differences in receptor assembly. However, structural in- assemble receptors, accounting for the differences in type I affinity formation for how activins assemble a ternary receptor complex is (7–11). The ternary structure of BMP2 revealed independent re- lacking. We report the structure of an activin class member, ceptor binding sites, with the type II receptors binding on the GDF11, in complex with the type II receptor ActRIIB and the type convex “knuckle” region of the ligand and the type I receptors I receptor Alk5. The structure reveals that receptor positioning is binding through extensive contacts in the concave cleft formed by similar to the BMP class, with no interreceptor contacts; however, the “wrist helix” at the dimer interface (12). In stark contrast, the type I receptor interactions are shifted toward the ligand fin- receptor binding for TGFβ ligands uses a cooperative assembly gertips and away from the dimer interface. Mutational analysis mechanism that facilitates binding of the type I receptor. Here, the BIOCHEMISTRY shows that ligand type I specificity is derived from differences in type II receptor is shifted toward the ligand fingertips and comes the fingertips of the ligands that interact with an extended loop into direct contact with the type I receptor; thus, binding of the specific to Alk4 and Alk5. The study also reveals differences for type I receptor is significantly stronger when the ligand is pre- how TGFβ and GDF11 bind to the same type I receptor, Alk5. For occupied with the type II receptor (9, 10). These studies highlight GDF11, additional contacts at the fingertip region substitute that different mechanisms of ligand–receptor interactions have for the interreceptor interactions that are seen for TGFβ, indicating emerged within the TGFβ family. that Alk5 binding to GDF11 is more dependent on direct contacts. In support, we show that a single residue of Alk5 (Phe84), when mutated, abolishes GDF11 signaling, but has little impact on TGFβ Significance signaling. The structure of GDF11/ActRIIB/Alk5 shows that, across the TGFβ family, different mechanisms regulate type I receptor bind- The TGFβ family of ligands plays fundamental roles in con- ing and specificity, providing a molecular explanation for how the trolling diverse signaling events throughout multicellular or- activin class accommodates low-affinity type I interactions without ganisms. The family is divided into 3 classes: activin, BMP, and the requirement of cooperative receptor interactions. TGFβ, with each signaling through specific combinations of type I and type II receptors. We demonstrate that activin li- GDF11 | TGF-β superfamily | activin | ternary signaling complex | Alk5 gands bind receptors similarly to BMP ligands, but they utilize the ligand fingertip to make specificity-determining contacts he transforming growth factor β (TGFβ) family of ligands is with the type I receptors. We also show that different molec- β Tcomposed of more than 30 dimeric growth factors essential in ular mechanisms have emerged for how GDF11 and TGF bind the development and homeostasis of all animals (1–3). Signaling the same type I receptor, whereby GDF11 is more dependent occurs when ligands engage 2 type I and 2 type II serine/threo- on direct receptor contacts. Thus, this study provides insight at nine kinase receptors, forming a hexameric signaling complex (4, the molecular level into how the activin class ligands bind and 5). Both the type I and type II receptors consist of a small ex- assemble their type I and type II receptors. tracellular ligand-binding domain tethered to an intracellular Author contributions: E.J.G., R.A.C., V.J.I., A.N.E., and T.B.T. designed research; E.J.G., kinase domain. Upon assembly, type II receptors phosphorylate R.A.C., M.C., V.J.I., and A.N.E. performed research; C.S.H., R.C., R.G., A.B., G.M., P.T.F., and activate the type I receptors, which, in turn, phosphorylate M.M.M., R.K., and A.P.H. contributed new reagents/analytic tools; E.J.G., R.A.C., V.J.I., intracellular SMAD proteins. Signaling is then transduced into the A.N.E., and T.B.T. analyzed data; and E.J.G. and T.B.T. wrote the paper. nucleus, where activated SMADs act as transcriptional factors, Conflict of interest statement: T.B.T. is a consultant for Acceleron Pharma and Scientific enabling signaling outcomes dependent on ligand–receptor com- Founder for Eclode. R.C. and R.K. are current employees of Acceleron Pharma with ownership interest in the company. A.N.E. and V.J.I. are current employees of Regeneron Pharmaceuticals binations. Given the diversity of biological responses and pro- with ownership interest in the company. The other authors report no competing cesses controlled by the family, it is somewhat surprising that only interests. 7 type I and 5 type II receptors are found within mammals (1). This article is a PNAS Direct Submission. Based on sequence homology and receptor utilization, the Published under the PNAS license. β TGF family can be divided into 3 general classes of ligands: Data deposition: The ternary structure of GDF11 bound to ActRIIB-ECD and Alk5-ECD activins, BMPs, and TGFβs. From this, 2 general signaling par- described in this paper has been deposited to the Protein Data Bank, http://www.rcsb. adigms have emerged—the TGFβ class, which activates SMAD org/ (accession code 6MAC). 2/3; and the BMP class, which activates SMAD 1/5/8—with 1To whom correspondence may be addressed. Email: [email protected]. specificity for each paradigm dependent on the activation of This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. different type I receptors. Interestingly, ligands have different 1073/pnas.1906253116/-/DCSupplemental. affinities for type I receptors, with BMP class ligands binding type Published online July 17, 2019. www.pnas.org/cgi/doi/10.1073/pnas.1906253116 PNAS | July 30, 2019 | vol. 116 | no. 31 | 15505–15513 Downloaded by guest on September 30, 2021 The activin class, which includes activin A (ActA), activin B (ActB), Growth and Differentiation Factor 8 (GDF8), and GDF11, shares aspects of both the TGFβ and BMP signaling paradigms. Similar to TGFβ, activin class ligands bind type II receptors with high affinity, including ActRIIA and ActRIIB, and type I receptors with very low affinity, to activating SMAD2/ 3 (1). However, type II receptor positioning for the activin class is similar to BMP ligands, suggesting that a cooperative mecha- nism between type I and type II receptors is not used by activin ligands to facilitate binding of the low-affinity type I receptors, as is the case for TGFβ (13, 14). Whereas TGFβ primarily signals use the type I receptor Activin receptor-like kinase 5 (Alk5), the activin class ligands are more promiscuous and can use different combinations of the type I receptors: Alk4, Alk5, and Alk7 (15– 17). For example, whereas ActA predominantly signals using Alk4, ActB can signal effectively using both Alk4 and Alk7 (5, 18, 19). GDF8 and GDF11 can both signal using Alk4 and Alk5, with GDF11 extending specificity to Alk7 (17). Although struc- tural studies have revealed how the TGFβ and the BMP ligands assemble the type I and type II receptors, the molecular details for how activin class ligands form a ternary signaling complex and account for type I receptor specificity is unknown. To ad- dress this, we sought to structurally characterize a ternary com- plex of an activin class ligand. Results and Discussion Ternary Complex Structure of GDF11/ActRIIB-ECD/Alk5-ECD. Crystals of an activin class ternary complex were generated by combining Fig. 1. Structure of GDF11/ActRIIB/Alk5 ternary complex. (A) GDF11/ActRIIB/ GDF11 and the ectodomains (ECDs) of both the high-affinity Alk5 as viewed on the membrane surface. GDF11 has 2 monomers repre- type II receptor ActRIIB and the low-affinity type I receptor sented in slate (monomer A) and cyan (monomer B). ActRIIB-ECD is repre- Alk5. Diffraction data were collected to 2.3-Å resolution, and the sented in orange, with Alk5-ECD in yellow. (B) Ninety-degree upward view structure was solved by molecular replacement using the previ- of the ternary complex. ActRIIB binds at the convex knuckle region of ously determined individual components as search models (data GDF11 whereas Alk5 binds at the concave interface of GDF11 formed be- collection and refinement statistics are provided in SI Appendix, tween the fingertip of monomer A and the wrist helix of monomer B GDF11.
Load more

Recommended publications
  • The Role of Follistatin-Like 3 (Fstl3) In
    THE ROLE OF FOLLISTATIN-LIKE 3 (FSTL3) IN CARDIAC HYPERTROPHY AND REMODELLING Kalyani Panse A thesis submitted for the degree of Doctor of Philosophy and the Diploma of Imperial College Harefield Heart Science Centre National Heart & Lung Institute Imperial College London May 2011 1 ABSTRACT Follistatins are extracellular inhibitors of TGF-β family ligands like activin A, myostatin and bone morphogenetic proteins. Follistatin-like 3 (Fstl3) is a potent inhibitor of activin signalling and antagonises the cardioprotective role of activin A in the heart. The expression of Fstl3 is elevated in patients with heart failure and upregulated by hypertrophic stimuli in cardiomyocytes. However its role in cardiac remodelling is largely unknown. The aim of this thesis was to analyse the function of Fstl3 in the myocardium in response to hypertrophic stimuli using both in vivo and in vitro approaches. To explore the role of Fstl3 in cardiac hypertrophy, cardiac-specific Fstl3 knock-out mice (Fstl3 KO) were subjected to pressure overload induced by trans-aortic constriction. They showed attenuated cardiac hypertrophy and improved cardiac function compared to wild type littermate control mice. Knock-out of Fstl3 specifically from cardiomyocytes was sufficient to reduce the total expression of Fstl3 in the heart following pressure overload, implying that cardiomyocytes are the major source of Fstl3 in the heart after TAC. Fstl3 KO mice also showed reduced expression of typical hypertrophic markers including ANP, BNP, α-skeletal actin and β-MHC. Similarly, treatment of neonatal rat cardiomyocytes with Fstl3 resulted in hypertrophy as measured by increased cell size and protein synthesis. This was also accompanied by activation of p38 and JNK signalling pathways.
    [Show full text]
  • FSTL3 Antibody / Follistatin-Like 3 (R31015)
    FSTL3 Antibody / Follistatin-like 3 (R31015) Catalog No. Formulation Size R31015 0.5mg/ml if reconstituted with 0.2ml sterile DI water 100 ug Bulk quote request Availability 1-3 business days Species Reactivity Human, Mouse, Rat Format Antigen affinity purified Clonality Polyclonal (rabbit origin) Isotype Rabbit IgG Purity Antigen affinity Buffer Lyophilized from 1X PBS with 2.5% BSA and 0.025% sodium azide/thimerosal UniProt O95633 Applications Western blot : 0.5-1ug/ml Limitations This FSTL3 antibody is available for research use only. Western blot testing of 1) rat liver, 2) rat testis, 3) rat NRK cell, 4) mouse liver, 5) mouse testis and 6) mouse lung lysate with FSTL3 antibody. Expected molecular weight: 25-39 kDa depending on glycosylation level. Western blot testing of human 1) U-2 OS, 2) HeLa, 3) A549, 4) PC-3, 5) HepG2 and 6) K562 cell lysate with FSTL3 antibody. Expected molecular weight: 25-39 kDa depending on glycosylation level. Description Follistatin-Like 3, also known as FLRG, is a member of the follistatin-module protein family, which is composed of extracellular matrix-associated glycoproteins thought to act in a paracrine manner to bind morphogens or growth/differentiation factors and regulate their activity during development. The FSTL3 gene extends over 7 kbp and contains 5 exons. By Southern blot analysis of somatic cell hybrids and FISH, Hayette et al.(1998) localized the gene to chromosome 19p13. Using recombinant mouse protein, Tsuchida et al.(2000) found that FSTL3 bound both activin and BMP2 and had a higher affinity for activin. Overexpression of the protein inhibited BMP2-induced cell signaling in a reporter assay.
    [Show full text]
  • Unifying the Genomics-Based Classes of Cancer Fusion Gene Partners: Large Cancer Fusion Genes Are Evolutionarily Conserved
    CANCER GENOMICS & PROTEOMICS 9: 389-396 (2012) Unifying the Genomics-based Classes of Cancer Fusion Gene Partners: Large Cancer Fusion Genes Are Evolutionarily Conserved LIBIA M. PAVA, DANIEL T. MORTON, REN CHEN and GEORGE BLANCK Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, U.S.A. Abstract. Background: Genes that fuse to cause cancer have fusion of NPM and ALK in anaplastic large-cell lymphoma been studied to determine molecular bases for proliferation, to (3); ABL and BCR in chronic myelogenous leukemia (CML) develop diagnostic tools, and as targets for drugs. To facilitate (4, 5); and C-MYC and IgH in Burkitt’s lymphoma in (6), identification of additional, cancer fusion genes, following among many others. The detection and understanding of the observation of a chromosomal translocation, we have ABL-BCR fusion protein, which stimulates unregulated cell characterized the genomic features of the fusion gene partners. division and leads to leukemia, led to the development of Previous work indicated that cancer fusion gene partners, are Gleevec, a drug able to block the ATP-binding site of the either large or evolutionarily conserved in comparison to the tyrosine kinase domain of ABL-BCR, halting CML (7). This neighboring genes in the region of a chromosomal extraordinary success has led to the hope of designing drugs translocation. These results raised the question of whether targeted against other cancer fusion proteins. large cancer fusion gene partners were also evolutionarily There are about 50,000 unstudied translocations, raising conserved. Methods and Results: We developed two methods the question of whether that information can continue to be for quantifying evolutionary conservation values, allowing the used to facilitate the identification of fusion genes.
    [Show full text]
  • UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent Permalink https://escholarship.org/uc/item/7m04f0b0 Author Buchholz, Kyle Stephen Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioengineering by Kyle Stephen Buchholz Committee in Charge: Professor Jeffrey Omens, Chair Professor Andrew McCulloch, Co-Chair Professor Ju Chen Professor Karen Christman Professor Robert Ross Professor Alexander Zambon 2016 Copyright Kyle Stephen Buchholz, 2016 All rights reserved Signature Page The Dissertation of Kyle Stephen Buchholz is approved and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California, San Diego 2016 iii Dedication To my beautiful wife, Rhia. iv Table of Contents Signature Page ................................................................................................................... iii Dedication .......................................................................................................................... iv Table of Contents ................................................................................................................ v List of Figures ...................................................................................................................
    [Show full text]
  • (NF1) As a Breast Cancer Driver
    INVESTIGATION Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver Marsha D. Wallace,*,† Adam D. Pfefferle,‡,§,1 Lishuang Shen,*,1 Adrian J. McNairn,* Ethan G. Cerami,** Barbara L. Fallon,* Vera D. Rinaldi,* Teresa L. Southard,*,†† Charles M. Perou,‡,§,‡‡ and John C. Schimenti*,†,§§,2 *Department of Biomedical Sciences, †Department of Molecular Biology and Genetics, ††Section of Anatomic Pathology, and §§Center for Vertebrate Genomics, Cornell University, Ithaca, New York 14853, ‡Department of Pathology and Laboratory Medicine, §Lineberger Comprehensive Cancer Center, and ‡‡Department of Genetics, University of North Carolina, Chapel Hill, North Carolina 27514, and **Memorial Sloan-Kettering Cancer Center, New York, New York 10065 ABSTRACT Identifying genomic alterations driving breast cancer is complicated by tumor diversity and genetic heterogeneity. Relevant mouse models are powerful for untangling this problem because such heterogeneity can be controlled. Inbred Chaos3 mice exhibit high levels of genomic instability leading to mammary tumors that have tumor gene expression profiles closely resembling mature human mammary luminal cell signatures. We genomically characterized mammary adenocarcinomas from these mice to identify cancer-causing genomic events that overlap common alterations in human breast cancer. Chaos3 tumors underwent recurrent copy number alterations (CNAs), particularly deletion of the RAS inhibitor Neurofibromin 1 (Nf1) in nearly all cases. These overlap with human CNAs including NF1, which is deleted or mutated in 27.7% of all breast carcinomas. Chaos3 mammary tumor cells exhibit RAS hyperactivation and increased sensitivity to RAS pathway inhibitors. These results indicate that spontaneous NF1 loss can drive breast cancer. This should be informative for treatment of the significant fraction of patients whose tumors bear NF1 mutations.
    [Show full text]
  • HER-2 Overexpression Differentially Alters
    Available online http://breast-cancer-research.com/content/7/6/R1058 ResearchVol 7 No 6 article Open Access HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells Cindy A Wilson1, Elaina E Cajulis2, Jennifer L Green3, Taylor M Olsen1, Young Ah Chung2, Michael A Damore2, Judy Dering1, Frank J Calzone2 and Dennis J Slamon1 1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA 2Amgen Inc., Thousand Oaks, CA 91320, USA 3Department of Biology, California Institute of Technology, Pasadena, CA 91125, USA Corresponding author: Cindy A Wilson, [email protected] Received: 20 Jul 2005 Revisions requested: 23 Aug 2005 Revisions received: 27 Sep 2005 Accepted: 6 Oct 2005 Published: 8 Nov 2005 Breast Cancer Research 2005, 7:R1058-R1079 (DOI 10.1186/bcr1343) This article is online at: http://breast-cancer-research.com/content/7/6/R1058 © 2005 Wilson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction Amplification of the HER-2 receptor tyrosine binding assays, phospho-specific Smad antibodies, kinase has been implicated in the pathogenesis and aggressive immunofluorescent staining of Smad and Smad DNA binding behavior of approximately 25% of invasive human breast assays. cancers. Clinical and experimental evidence suggest that aberrant HER-2 signaling contributes to tumor initiation and Results We demonstrate that cells engineered to over-express disease progression.
    [Show full text]
  • An Integrative Genomic Analysis of the Longshanks Selection Experiment for Longer Limbs in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Title: 2 An integrative genomic analysis of the Longshanks selection experiment for longer limbs in mice 3 Short Title: 4 Genomic response to selection for longer limbs 5 One-sentence summary: 6 Genome sequencing of mice selected for longer limbs reveals that rapid selection response is 7 due to both discrete loci and polygenic adaptation 8 Authors: 9 João P. L. Castro 1,*, Michelle N. Yancoskie 1,*, Marta Marchini 2, Stefanie Belohlavy 3, Marek 10 Kučka 1, William H. Beluch 1, Ronald Naumann 4, Isabella Skuplik 2, John Cobb 2, Nick H. 11 Barton 3, Campbell Rolian2,†, Yingguang Frank Chan 1,† 12 Affiliations: 13 1. Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany 14 2. University of Calgary, Calgary AB, Canada 15 3. IST Austria, Klosterneuburg, Austria 16 4. Max Planck Institute for Cell Biology and Genetics, Dresden, Germany 17 Corresponding author: 18 Campbell Rolian 19 Yingguang Frank Chan 20 * indicates equal contribution 21 † indicates equal contribution 22 Abstract: 23 Evolutionary studies are often limited by missing data that are critical to understanding the 24 history of selection. Selection experiments, which reproduce rapid evolution under controlled 25 conditions, are excellent tools to study how genomes evolve under strong selection. Here we 1 bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018.
    [Show full text]
  • Systematic Analysis, Comparison, and Integration of Disease Based Human
    Zhang et al. BMC Medical Genomics 2010, 3:1 http://www.biomedcentral.com/1755-8794/3/1 RESEARCH ARTICLE Open Access Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information Yonqing Zhang1†, Supriyo De1†, John R Garner1, Kirstin Smith1, S Alex Wang2, Kevin G Becker1* Abstract Background: The genetic contributions to human common disorders and mouse genetic models of disease are complex and often overlapping. In common human diseases, unlike classical Mendelian disorders, genetic factors generally have small effect sizes, are multifactorial, and are highly pleiotropic. Likewise, mouse genetic models of disease often have pleiotropic and overlapping phenotypes. Moreover, phenotypic descriptions in the literature in both human and mouse are often poorly characterized and difficult to compare directly. Methods: In this report, human genetic association results from the literature are summarized with regard to replication, disease phenotype, and gene specific results; and organized in the context of a systematic disease ontology. Similarly summarized mouse genetic disease models are organized within the Mammalian Phenotype ontology. Human and mouse disease and phenotype based gene sets are identified. These disease gene sets are then compared individually and in large groups through dendrogram analysis and hierarchical clustering analysis. Results: Human disease and mouse phenotype gene sets are shown to group into disease and phenotypically relevant groups at both a coarse and fine level based on gene sharing. Conclusion: This analysis provides a systematic and global perspective on the genetics of common human disease as compared to itself and in the context of mouse genetic models of disease.
    [Show full text]
  • Retinal Genomic Fabric Remodeling After Optic Nerve Injury
    G C A T T A C G G C A T genes Article Retinal Genomic Fabric Remodeling after Optic Nerve Injury Pedro Henrique Victorino 1 , Camila Marra 1, Dumitru Andrei Iacobas 2,3 , Sanda Iacobas 4, David C. Spray 3, Rafael Linden 1 , Daniel Adesse 5,*,† and Hilda Petrs-Silva 1,*,† 1 Laboratório de Neurogênese, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil; [email protected] (P.H.V.); [email protected] (C.M.); [email protected] (R.L.) 2 Personalized Genomics Laboratory, Center for Computational Systems Biology, Prairie View A&M University, Prairie View, TX 77446, USA; [email protected] 3 Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA; [email protected] 4 Department of Pathology, New York Medical College, Valhalla, NY 10595, USA; [email protected] 5 Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil * Correspondence: adesse@ioc.fiocruz.br (D.A.); hilda.ufl@gmail.com (H.P.-S.) † Both contributed as equal senior authors. Abstract: Glaucoma is a multifactorial neurodegenerative disease, characterized by degeneration of the retinal ganglion cells (RGCs). There has been little progress in developing efficient strategies for neuroprotection in glaucoma. We profiled the retina transcriptome of Lister Hooded rats at 2 weeks after optic nerve crush (ONC) and analyzed the data from the genomic fabric paradigm (GFP) to bring additional insights into the molecular mechanisms of the retinal remodeling after induction of RGC degeneration. GFP considers three independent characteristics for the expression of each gene: level, variability, and correlation with each other gene.
    [Show full text]
  • Regulation of Follistatin-Like 3 Expression by Mir-486-5P Modulates Gastric Cancer Cell Proliferation, Migration and Tumor Progression
    www.aging-us.com AGING 2021, Vol. 13, No. 16 Research Paper Regulation of follistatin-like 3 expression by miR-486-5p modulates gastric cancer cell proliferation, migration and tumor progression Zhou-Tong Dai1,*, Yuan Xiang1,2,*, Xiao-Yu Zhang1,*, Qi-Bei Zong1, Qi-Fang Wu1, You Huang1, Chao Shen1, Jia-Peng Li1, Sreenivasan Ponnambalam3, Xing-Hua Liao1 1Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Hubei 430081, P.R. China 2Department of Medical Laboratory, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, P.R. China 3School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom *Equal contribution Correspondence to: Sreenivasan Ponnambalam, Xing-Hua Liao; email: [email protected]; [email protected], https://orcid.org/0000-0002-8067-4851 Keywords: follistatin, FSTL3, gastric cancer, miR-486-5p, cell proliferation Received: March 11, 2021 Accepted: August 2, 2021 Published: August 23, 2021 Copyright: © 2021 Dai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Cancer development and progression can be regulated by the levels of endogenous factors. Gastric cancer is an aggressive disease state with poor patient prognosis, needing the development of new diagnostics and therapeutic strategies. We investigated the close association between follistatin-like 3 (FSTL3) and different cancers, and focused on its role in gastric cancer cell function.
    [Show full text]
  • Omics Approaches in Adipose Tissue and Skeletal Muscle Addressing the Role of Extracellular Matrix in Obesity and Metabolic Dysfunction
    International Journal of Molecular Sciences Review Omics Approaches in Adipose Tissue and Skeletal Muscle Addressing the Role of Extracellular Matrix in Obesity and Metabolic Dysfunction Augusto Anguita-Ruiz 1,2,3,4 , Mireia Bustos-Aibar 1,3, Julio Plaza-Díaz 1,2,3,5 , Andrea Mendez-Gutierrez 1,2,3,4, Jesús Alcalá-Fdez 6 , Concepción María Aguilera 1,2,3,4,* and Francisco Javier Ruiz-Ojeda 1,2,7 1 Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, 18071 Granada, Spain; [email protected] (A.A.-R.); [email protected] (M.B.-A.); [email protected] (J.P.-D.); [email protected] (A.M.-G.); [email protected] (F.J.R.-O.) 2 Instituto de Investigación Biosanitaria IBS.GRANADA, Complejo Hospitalario Universitario de Granada, 18014 Granada, Spain 3 Institute of Nutrition and Food Technology “José Mataix”, Center of Biomedical Research, University of Granada, Avda. del Conocimiento s/n., 18016 Granada, Spain 4 CIBEROBN (CIBER Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, 28029 Madrid, Spain 5 Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada 6 Department of Computer Science and Artificial Intelligence, University of Granada, 18071 Granada, Spain; [email protected] 7 RG Adipocytes and Metabolism, Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Center Munich, Neuherberg, 85764 Munich, Germany Citation: Anguita-Ruiz, A.; * Correspondence: [email protected]; Tel.: +34-9-5824-1000 (ext. 20314) Bustos-Aibar, M.; Plaza-Díaz, J.; Mendez-Gutierrez, A.; Alcalá-Fdez, J.; Abstract: Extracellular matrix (ECM) remodeling plays important roles in both white adipose tissue Aguilera, C.M.; Ruiz-Ojeda, F.J.
    [Show full text]
  • Integrative Approach to Understanding the Multimodal Effects of Exercise Adaptation
    Integrative Approach to Understanding the Multimodal Effects of Exercise Adaptation DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Alisa D. Blazek, M.A. Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2015 Dissertation Committee: Dr. Noah L. Weisleder, Advisor Dr. Timothy E. Hewett Dr. Sudha Agarwal Dr. Timothy D. Eubank Copyright by Alisa D. Blazek 2015 Abstract The study of the molecular basis of exercise adaptations in the field of exercise physiology is relatively new, as evidenced by the surge in articles citing molecular techniques over the last decade. This focus on molecular indicators is not surprising given the efforts to improve upon preventative healthcare and reduce healthcare cost burden in our country. The ability to exploit molecular indicators of exercise effectiveness as well as discover novel therapeutic options are clear advantages to studying molecular exercise physiology that could impact healthcare. In the studies described here, we used an integrative approach, building from a molecular basis to mice to human subjects, to develop a more comprehensive understanding of the molecular mechanisms mediating the effects of exercise. To study the effects of exercise on a physiological systems-wide level, we used microarray technology to characterize global upregulation and downregulation of genes in response to walking exercise in rat cartilage. We found temporal gene expression changes over 15 days of exercise. The networks of genes affected were responsible for directing extracellular matrix; cell metabolism; cytoskeleton; cell signaling, growth, and differentiation; and inflammatory pathways.
    [Show full text]